Status:
COMPLETED
Incremental Hemodialysis as a Starting Way of Renal Replacement Therapy
Lead Sponsor:
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Conditions:
Chronic Renal Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The Hemodialysis Unit of the Hospital Ramon y Cajal is a pioneer in the implementation of a program of incremental hemodialysis, starting with two sessions a week in patients with residual renal funct...
Detailed Description
The primary specific objective is to assess the loss of renal function defined as 24 hours diuresis less than 100 ml at 12 months of starting treatment. Secondary objectives are: erythropoietin dose, ...
Eligibility Criteria
Inclusion
- Subjects starting renal replacement therapy from January 2017 to June 2018.
- Subjects who consent to sign the Informed Consent Form.
- Subject who maintain residual diuresis and urea clearance equal or superior to 2,5 ml/min.
Exclusion
- Anuric patients.
- Patients with acute renal failure.
- Patients who revoke the Informed Consent Form.
- Patients who start hemodialysis after having going through a renal transplant.
Key Trial Info
Start Date :
April 4 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2022
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03302546
Start Date
April 4 2017
End Date
December 30 2022
Last Update
May 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Ramón y Cajal
Madrid, Spain, 28034